Soft-tissue / hard-material interaction. A research prototype for overseas technical evaluation and export business discussions only.

Centre wavelength
1940nm+1550nm
Max. average power · pulsed
80 W
Max. average power · continuous
120 W
Cooling
Air cooling
This 1940nm thulium fibre laser platform supports both soft-tissue interaction and lithotripsy working modes in a single unit. Its integrated, air-cooled design runs on standard mains power and is intended for urological application development for overseas markets.
Research prototype, not registered in China. For overseas technical evaluation only; not a medical device marketed in mainland China.
The 1940nm wavelength lies in a high-absorption band for water, with a high absorption coefficient in tissue water and shallow optical penetration. The fibre-laser architecture supports continuous and pulsed output. Energy at this wavelength is predominantly absorbed by water in the medium; parameter adjustments enable thermal tissue interaction or pulsed impulse effects.

Wavelength absorption curves from the supplied technical material. This diagram illustrates optical mechanisms, not clinical efficacy.
Horizontal axis: laser wavelength (nm). Vertical axis: absorption coefficient (cm⁻¹). Cyan: water (H₂O); red: haemoglobin. Markers: green laser 532nm; 980nm; neodymium laser 1064nm; 1470nm; thulium fibre laser 1940nm; solid-state thulium laser 2013nm; holmium laser 2100nm.
A 1940nm thulium fibre laser source with a design life of up to 100,000 hours. Integrated construction provides interference resistance and low maintenance requirements.
Switchable continuous-wave and pulsed-wave output allows parameters to be configured for different working scenarios. Dedicated delivery fibres can be specified to suit the task.
Air cooling requires no external water-cooling unit. The integrated trolley console includes a touchscreen terminal and runs on standard mains power, reducing operating-room infrastructure requirements and allowing flexible deployment.
Technical note: final clinical performance depends on complete registration in the target market, the clinical protocol, operator expertise and the choice of compatible consumables. This material makes no guarantee of any clinical outcome.